Table 2.
Univariable Cox regression analyses for the volumes of interest of MTV
| Overall survival | Disease-free survival | |||||
|---|---|---|---|---|---|---|
| HR (95% CI)ª | p-value | C-index | HR (95% CI)ª | p-value | C-index | |
| T MTV with SUV2.5 threshold | 1.02 (1.01–1.03) | 0.009 | 0.656 | 1.02 (1.01–1.03) | 0.002 | 0.695 |
| N MTV with SUV2.5 threshold | 1.01 (1.003–1.027) | 0.013 | 0.586 | 1.01 (1.003–1.02) | 0.012 | 0.587 |
| T + N with MTV SUV2.5 threshold | 1.01 (1.01–1.02) | 0.002 | 0.667 | 1.01 (1.01–1.02) | < 0.001 | 0.703 |
| T MTV with background-level threshold | 1.02 (1.01–1.04) | 0.005 | 0.659 | 1.03 (1.01–1.0) | 0.001 | 0.688 |
| N MTV with background-level threshold | 1.02 (1.004–1.04) | 0.011 | 0.575 | 1.01 (1.002–1.03) | 0.025 | 0.574 |
| T + N MTV with background-level threshold | 1.02 (1.01–1.03) | 0.002 | 0.656 | 1.02 (1.01–1.03) | < 0.001 | 0.681 |
ªPer unit increment
HR hazard ratio, CI confidence interval, MTV metabolic tumor volume, C-index Harrell’s C-index, SUV standardized uptake value, T tumor, N lymph node